Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Pfizenmaier

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Frontiers in Pharmacology|June 13, 2020
A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer CellsFranziska Hartung, Thomas Krüwel, Xiaoyi Shi, et al.
The Journal of Cell Biology|March 30, 2005
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stabilityFrank Henkler, Eva Behrle, Kevin M Dennehy, et al.
Mabs|October 12, 2010
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibodyKirstin A Zettlitz, Verena Lorenz, Karlheinz Landauer, et al.
The Journal of Biological Chemistry|May 30, 2003
Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted ActivationDierk Samel, Dafne Muller, Jeannette Gerspach, et al.
Blood Advances|September 30, 2021
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced diseasePeter Müller, Conny K Baldauf, Tobias R Haage, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 25, 2009
Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cellsSylvia K E Messerschmidt, Anna Musyanovych, Martin Altvater, et al.
Scientific Reports|May 19, 2018
IgG-single-chain TRAIL fusion proteins for tumour therapyMartin Siegemund, Felix Schneider, Meike Hutt, et al.
Frontiers in Pharmacology|January 11, 2020
Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion ProteinTanja Padutsch, Maksim Sendetski, Carina Huber, et al.
Gene Expression Patterns : GEP|June 6, 2006
Drosophila protein kinase D is broadly expressed and a fraction localizes to the Golgi compartmentDieter Maier, Angelika Hausser, Anja C Nagel, et al.
Scientific Reports|July 28, 2017
Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2Roman Fischer, Jessica Marsal, Cristiano Guttà, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Frontiers in Pharmacology|June 13, 2020
A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer CellsFranziska Hartung, Thomas Krüwel, Xiaoyi Shi, et al.
The Journal of Cell Biology|March 30, 2005
The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stabilityFrank Henkler, Eva Behrle, Kevin M Dennehy, et al.
Mabs|October 12, 2010
ATROSAB, a humanized antagonistic anti-tumor necrosis factor receptor one-specific antibodyKirstin A Zettlitz, Verena Lorenz, Karlheinz Landauer, et al.
The Journal of Biological Chemistry|May 30, 2003
Generation of a FasL-based proapoptotic fusion protein devoid of systemic toxicity due to cell-surface antigen-restricted ActivationDierk Samel, Dafne Muller, Jeannette Gerspach, et al.
Blood Advances|September 30, 2021
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced diseasePeter Müller, Conny K Baldauf, Tobias R Haage, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 25, 2009
Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cellsSylvia K E Messerschmidt, Anna Musyanovych, Martin Altvater, et al.
Scientific Reports|May 19, 2018
IgG-single-chain TRAIL fusion proteins for tumour therapyMartin Siegemund, Felix Schneider, Meike Hutt, et al.
Frontiers in Pharmacology|January 11, 2020
Superior Treg-Expanding Properties of a Novel Dual-Acting Cytokine Fusion ProteinTanja Padutsch, Maksim Sendetski, Carina Huber, et al.
Gene Expression Patterns : GEP|June 6, 2006
Drosophila protein kinase D is broadly expressed and a fraction localizes to the Golgi compartmentDieter Maier, Angelika Hausser, Anja C Nagel, et al.
Scientific Reports|July 28, 2017
Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2Roman Fischer, Jessica Marsal, Cristiano Guttà, et al.
Pageof 10